Dr. Mcgary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6041 Cadillac Ave
Los Angeles, CA 90034Phone+1 323-857-2000
Education & Training
- Tulane University School of MedicineClass of 2011
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2000 - 2003
- Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1997 - 2000
Certifications & Licensure
- CA State Medical License 1998 - 2026
- SC State Medical License 2003 - 2005
- TX State Medical License 2001 - 2003
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- Impact of pharmacist managed oral epidermal growth factor receptor inhibitors.Shirley Ng, Nicholas Baker, Fang Niu, Jed A Katzel, Hanh T Bergere
Journal of Oncology Pharmacy Practice. 2024-07-23 - 50 citationsSWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (...Martin J. Edelman, Mary W. Redman, Kathy S. Albain, Eric C. McGary, Noman M. Rafique
Journal of Thoracic Oncology. 2019-10-01 - Editor's Note: Inhibition of Platelet-derived Growth Factor-mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571.Eric C McGary, Kristy Weber, Lisa Mills, Michelle Doucet, Valerie Lewis
Clinical Cancer Research. 2019-05-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: